Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells

Li,Ronghui; Sun,Yingyan; Jiang,Aiying; Wu,Yan; Li,Chengwei; Jin,Mingchun; Yan,Hairun; Jin,Hong

doi:10.3892/mmr.2016.4904

Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells

Authors:
- Ronghui Li
- Yingyan Sun
- Aiying Jiang
- Yan Wu
- Chengwei Li
- Mingchun Jin
- Hairun Yan
- Hong Jin
View Affiliations

Affiliations: Department of Clinical Laboratory, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China, Department of Ultrasonography, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China, Department of Pneumology, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China, Department of Medical Research Center, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China
Published online on: February 18, 2016 https://doi.org/10.3892/mmr.2016.4904
Pages: 3190-3196

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have demonstrated that ephrin (Eph) family receptor tyrosine kinases and ligands promote cancer growth, invasion and metastasis. In addition, it has been reported that Eph receptor A7 (EphA7) is transcriptionally activated in lung cancer; however, the effects of silencing EphA7 expression on the growth of lung cancer cells, and the underlying molecular mechanisms, have yet to be determined. Therefore, the present study aimed to investigate whether silencing EphA7 with small interfering (si)RNA could induce apoptosis in non‑small cell lung cancer (NSCLC) cells. Furthermore, the effects of siEphA7 on cell migration and invasion were evaluated using Transwell assays. The mechanisms underlying the effects of siEphA7 on the tumorigenic properties of A549 cells were also examined. The results of the present study demonstrated that transfection with siEphA7 inhibited the proliferation, migration and invasion of A549 cells. In addition, siEphA7 significantly increased the protein expression levels of B‑cell lymphoma 2 (Bcl‑2)‑associated X protein and caspase‑3, and decreased the protein expression levels of Bcl‑2, thus suggesting that siEphA7 was able to induce apoptosis via the intrinsic apoptotic pathway. In addition, the expression levels of phosphatase and tensin homolog (PTEN) were significantly upregulated, and the expression levels of total AKT were not altered, whereas the levels of phosphorylated‑AKT were reduced. These findings indicated that EphA7 may have an important role in the pathogenesis of NSCLC by regulating PTEN expression via the PTEN/AKT pathway. Silencing EphA7 may provide a novel approach for the treatment of NSCLC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Wang L, Xiong Y, Sun Y, Fang Z, Li L, Ji H and Shi T: HLungDB: An integrated database of human lung cancer research. Nucleic Acids Res. 38(Database Issue): D665–D669. 2010. View Article : Google Scholar :
3	Inamura K and Ishikawa Y: Lung cancer progression and metastasis from the prognostic point of view. Clin Exp Metastasis. 27:389–397. 2010. View Article : Google Scholar : PubMed/NCBI
4	Mihaljevic AL, Michalski CW, Friess H and Kleeff J: Molecular mechanism of pancreatic cancer - understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg. 395:295–308. 2010. View Article : Google Scholar : PubMed/NCBI
5	Hoon DS, Ferris R, Tanaka R, Chong KK, Alix-Panabières C and Pantel K: Molecular mechanisms of metastasis. J Surg Oncol. 103:508–517. 2011. View Article : Google Scholar : PubMed/NCBI
6	van der Geer P, Hunter T and Lindberg RA: Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol. 10:251–337. 1994. View Article : Google Scholar : PubMed/NCBI
7	Pasquale EB: Eph receptors and ephrins in cancer: Bidirectional signalling and beyond. Nat Rev Cancer. 10:165–180. 2010. View Article : Google Scholar : PubMed/NCBI
8	Matsumura Y, Umemura S, Ishii G, Tsuta K, Matsumoto S, Aokage K, Hishida T, Yoshida J, Ohe Y, Suzuki H, et al: Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: A comparative analysis with adenocarcinoma and squamous cell carcinoma. J Cancer Res Clin Oncol. 141:2159–70. 2015. View Article : Google Scholar : PubMed/NCBI
9	Eph Nomenclature Committee: Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell. 90:403–404. 1997. View Article : Google Scholar
10	Kiyokawa E, Takai S, Tanaka M, Iwase T, Suzuki M, Xiang YY, Naito Y, Yamada K, Sugimura H and Kino I: Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res. 54:3645–3650. 1994.PubMed/NCBI
11	Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE and Ikegaki N: Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci USA. 97:10936–10941. 2000. View Article : Google Scholar : PubMed/NCBI
12	Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ and Kinch MS: Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate. 41:275–280. 1999. View Article : Google Scholar : PubMed/NCBI
13	Taneja R, Thisse B, Rijli FM, Thisse C, Bouillet P, Dollé P and Chambon P: The expression pattern of the mouse receptor tyrosine kinase gene MDK1 is conserved through evolution and requires Hoxa-2 for rhombomere-specific expression in mouse embryos. Dev Biol. 177:397–412. 1996. View Article : Google Scholar : PubMed/NCBI
14	Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T, Dietmaier W, Landthaler M and Vogt T: Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem. 50:490–499. 2004. View Article : Google Scholar : PubMed/NCBI
15	Surawska H, Ma PC and Salgia R: The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev. 15:419–433. 2004. View Article : Google Scholar : PubMed/NCBI
16	Nakanishi H, Nakamura T, Canaani E and Croce CM: ALL1 fusion proteins induce deregulation of EphA7 and ERK phos-phorylation in human acute leukemias. Proc Natl Acad Sci USA. 104:14442–14447. 2007. View Article : Google Scholar
17	Wu Z, Liu K, Wang Y, Xu Z, Meng J and Gu S: Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer. Cancer Cell Int. 15:1072015. View Article : Google Scholar : PubMed/NCBI
18	Suen DF, Norris KL and Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590. 2008. View Article : Google Scholar : PubMed/NCBI
19	Slee EA, Adrain C and Martin SJ: Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem. 276:7320–7326. 2001. View Article : Google Scholar
20	Liu S, Cheng L, Bi X, Zhang X, Liu S, Bai X, Li F and Zhao AZ: Elevation of ω-3 polyunsaturated fatty acids attenuates PTEN-deficiency induced endometrial cancer development through regulation of COX-2 and PGE2 production. Sci Rep. 5:14958
21	Kinch MS, Moore MB and Harpole DH Jr: Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res. 9:613–618. 2003.PubMed/NCBI
22	Kataoka H, Igarashi H, Kanamori M, Ihara M, Wang JD, Wang YJ, Li ZY, Shimamura T, Kobayashi T, Maruyama K, et al: Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer. Cancer Sci. 95:136–141. 2004. View Article : Google Scholar : PubMed/NCBI
23	Nakamura R, Kataoka H, Sato N, Kanamori M, Ihara M, Igarashi H, Ravshanov S, Wang YJ, Li ZY, Shimamura T, et al: EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci. 96:42–47. 2005. View Article : Google Scholar : PubMed/NCBI
24	Martinou JC and Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol. 2:63–67. 2001. View Article : Google Scholar : PubMed/NCBI
25	Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F and Youle RJ: Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J. 22:4385–4399. 2003. View Article : Google Scholar : PubMed/NCBI